Cardiovascular and diabetes risk perception in a Hispanic community sample
Vanessa A Diaz1, Arch G Mainous, Deborah Williamson
1Department of Family Medicine, Medical University of South Carolina, Charleston 29425, USA. diazva@musc.edu
Ethnicity & Disease
|July 11, 2012
Summary
Many Hispanic adults underestimate their risk for coronary heart disease (CHD) and undiagnosed diabetes. Improving risk perception through health education is crucial for this community.
Area of Science:
- Cardiovascular Health
- Diabetes Mellitus Research
- Health Disparities
Background:
- Accurate risk perception is vital for preventive health behaviors.
- Hispanic adults face a disproportionately high burden of cardiovascular disease and diabetes.
- Understanding risk perception gaps is key to targeted health interventions.
Purpose of the Study:
- To compare perceived 10-year coronary heart disease (CHD) risk with actual risk in Hispanic adults.
- To assess perceived likelihood of undiagnosed diabetes or impaired fasting glucose (IFG) against calculated risk in this population.
Main Methods:
- A survey of 183 Hispanic adults in Charleston, SC.
- Calculation of 10-year CHD risk and likelihood of undiagnosed diabetes/IFG.
- Utilized the Risk Perception Survey-Diabetes Mellitus for perceived risk assessment.
Main Results:
- Over half (54.8%) underestimated their risk of undiagnosed diabetes/IFG; 14.8% underestimated their 10-year CHD risk.
- Older, overweight, and male respondents were more likely to underestimate their risks.
- Family history of diabetes was associated with lower underestimation of diabetes risk, while diagnosed hypertension, diabetes, high cholesterol, or family history of heart attack increased CHD risk underestimation.
Conclusions:
- Significant underestimation of cardiovascular and diabetes risk exists within the surveyed Hispanic adult community.
- Targeted health education is needed to enhance accurate risk perception.
- Improving risk perception can be a pathway to better health promotion and disease prevention strategies.
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
